Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 6
1973 3
1974 6
1975 7
1976 7
1977 6
1978 5
1979 3
1980 2
1981 8
1982 10
1983 3
1984 10
1985 9
1986 10
1987 8
1988 10
1989 8
1990 12
1991 5
1992 11
1993 12
1994 6
1995 8
1996 5
1997 7
1998 7
1999 11
2000 15
2001 13
2002 7
2003 17
2004 20
2005 12
2006 19
2007 27
2008 30
2009 12
2010 17
2011 26
2012 52
2013 60
2014 40
2015 43
2016 45
2017 66
2018 67
2019 64
2020 43
2021 48
2022 40
2023 55
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

998 results

Results by year

Filters applied: . Clear all
Page 1
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial.
Shitara K, Lordick F, Bang YJ, Enzinger P, Ilson D, Shah MA, Van Cutsem E, Xu RH, Aprile G, Xu J, Chao J, Pazo-Cid R, Kang YK, Yang J, Moran D, Bhattacharya P, Arozullah A, Park JW, Oh M, Ajani JA. Shitara K, et al. Among authors: moran d. Lancet. 2023 May 20;401(10389):1655-1668. doi: 10.1016/S0140-6736(23)00620-7. Epub 2023 Apr 15. Lancet. 2023. PMID: 37068504 Clinical Trial.
Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial.
Shah MA, Shitara K, Ajani JA, Bang YJ, Enzinger P, Ilson D, Lordick F, Van Cutsem E, Gallego Plazas J, Huang J, Shen L, Oh SC, Sunpaweravong P, Soo Hoo HF, Turk HM, Oh M, Park JW, Moran D, Bhattacharya P, Arozullah A, Xu RH. Shah MA, et al. Among authors: moran d. Nat Med. 2023 Aug;29(8):2133-2141. doi: 10.1038/s41591-023-02465-7. Epub 2023 Jul 31. Nat Med. 2023. PMID: 37524953 Free PMC article. Clinical Trial.
ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma.
Klempner SJ, Lee KW, Shitara K, Metges JP, Lonardi S, Ilson DH, Fazio N, Kim TY, Bai LY, Moran D, Yang J, Arozullah A, Park JW, Raizer JJ, Bang YJ, Shah MA. Klempner SJ, et al. Among authors: moran d. Clin Cancer Res. 2023 Oct 2;29(19):3882-3891. doi: 10.1158/1078-0432.CCR-23-0204. Clin Cancer Res. 2023. PMID: 37490286 Free PMC article. Clinical Trial.
Meat market failure.
Moran D. Moran D. Nat Food. 2021 Feb;2(2):67. doi: 10.1038/s43016-021-00223-x. Nat Food. 2021. PMID: 37117402 No abstract available.
Editorial: Sustainable livestock systems for high-producing animals.
Simões J, Moran D, Edwards S, Bonnet C, Lopez-Sebastian A, Chemineau P. Simões J, et al. Among authors: moran d. Animal. 2021 Dec;15 Suppl 1:100371. doi: 10.1016/j.animal.2021.100371. Epub 2021 Oct 28. Animal. 2021. PMID: 34688563 Free article. No abstract available.
Forest-linked livelihoods in a globalized world.
Oldekop JA, Rasmussen LV, Agrawal A, Bebbington AJ, Meyfroidt P, Bengston DN, Blackman A, Brooks S, Davidson-Hunt I, Davies P, Dinsi SC, Fontana LB, Gumucio T, Kumar C, Kumar K, Moran D, Mwampamba TH, Nasi R, Nilsson M, Pinedo-Vasquez MA, Rhemtulla JM, Sutherland WJ, Watkins C, Wilson SJ. Oldekop JA, et al. Among authors: moran d. Nat Plants. 2020 Dec;6(12):1400-1407. doi: 10.1038/s41477-020-00814-9. Epub 2020 Nov 30. Nat Plants. 2020. PMID: 33257859 Review.
Local field potentials for BCI control.
Heldman DA, Moran DW. Heldman DA, et al. Among authors: moran dw. Handb Clin Neurol. 2020;168:279-288. doi: 10.1016/B978-0-444-63934-9.00020-2. Handb Clin Neurol. 2020. PMID: 32164859 Review.
Challenges of Gene Editing Therapies for Genodermatoses.
Brooks IR, Sheriff A, Moran D, Wang J, Jacków J. Brooks IR, et al. Among authors: moran d. Int J Mol Sci. 2023 Jan 24;24(3):2298. doi: 10.3390/ijms24032298. Int J Mol Sci. 2023. PMID: 36768619 Free PMC article. Review.
Managing hyponatremia in adults.
Moran D, Fronk C, Mandel E. Moran D, et al. JAAPA. 2014 Apr;27(4):23-9; quiz 30. doi: 10.1097/01.JAA.0000444730.86174.e8. JAAPA. 2014. PMID: 24622398 Review.
998 results